Lbp Am Sa Has $9 Million Stake in The Cigna Group (NYSE:CI)

Lbp Am Sa increased its holdings in shares of The Cigna Group (NYSE:CI) by 56.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,594 shares of the health services provider’s stock after buying an additional 11,732 shares during the period. Lbp Am Sa’s holdings in The Cigna Group were worth $9,001,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. Swedbank AB boosted its position in shares of The Cigna Group by 26.6% in the 3rd quarter. Swedbank AB now owns 570,283 shares of the health services provider’s stock worth $197,569,000 after purchasing an additional 119,681 shares during the last quarter. Harbour Investments Inc. boosted its holdings in The Cigna Group by 23.6% during the third quarter. Harbour Investments Inc. now owns 661 shares of the health services provider’s stock worth $229,000 after buying an additional 126 shares during the last quarter. Prime Capital Investment Advisors LLC grew its position in shares of The Cigna Group by 7.5% during the 3rd quarter. Prime Capital Investment Advisors LLC now owns 3,125 shares of the health services provider’s stock worth $1,082,000 after buying an additional 218 shares during the period. Aptus Capital Advisors LLC increased its stake in shares of The Cigna Group by 2.5% in the 3rd quarter. Aptus Capital Advisors LLC now owns 2,613 shares of the health services provider’s stock valued at $905,000 after acquiring an additional 64 shares during the last quarter. Finally, Haverford Trust Co raised its position in shares of The Cigna Group by 6.0% in the 3rd quarter. Haverford Trust Co now owns 2,408 shares of the health services provider’s stock valued at $834,000 after acquiring an additional 136 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group Trading Up 0.4 %

Shares of The Cigna Group stock opened at $313.35 on Friday. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The business’s 50 day moving average is $296.79 and its 200-day moving average is $316.78. The stock has a market cap of $85.76 billion, a P/E ratio of 25.60, a P/E/G ratio of 0.98 and a beta of 0.53.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the firm posted $6.79 earnings per share. Equities research analysts predict that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date of this dividend is Wednesday, March 5th. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s payout ratio is 49.35%.

Insider Buying and Selling at The Cigna Group

In related news, insider Nicole S. Jones sold 4,904 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the transaction, the insider now owns 29,421 shares in the company, valued at approximately $9,065,198.52. This represents a 14.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David Cordani sold 26,527 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now owns 127,767 shares of the company’s stock, valued at $39,367,568.04. This trade represents a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 41,375 shares of company stock worth $12,866,600 over the last 90 days. Company insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CI. Oppenheimer lowered their target price on shares of The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a research note on Friday, January 31st. Morgan Stanley decreased their target price on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Piper Sandler reiterated an “overweight” rating and set a $348.00 price objective (down previously from $394.00) on shares of The Cigna Group in a report on Monday, February 3rd. Stephens lowered their target price on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Finally, UBS Group cut their price target on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, The Cigna Group currently has an average rating of “Buy” and a consensus price target of $372.31.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.